NCT01350570View on ClinicalTrials.gov

Acupuncture for Patients With Diarrhea-predominant IBS or Functional Diarrhea: a Randomized Controlled Trial

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

449

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

February 28, 2014

Study Completion Date

September 30, 2014

Conditions
Diarrhea-predominant Irritable Bowel SyndromeFunctional Diarrhea
Interventions
OTHER

acupuncture

acupuncture group1, acupoints ST25 and BL25 will be used in this trial.

OTHER

acupuncture group2

Acupoints LI11 and ST37 will be used in this group. LI11 is located at upper limb while ST37 is located at the lower limb.

OTHER

acupuncture group3

All acupoints used in acupuncture group1 and group2 will be used in this group.

DRUG

Loperamide

Loperamide will be used in this group for a dose of 2mg a time, three time a day.

Trial Locations (1)

610075

First affiliated hospital of Chengdu university of TCM, Chengdu

All Listed Sponsors
collaborator

Guang'anmen Hospital of China Academy of Chinese Medical Sciences

OTHER

lead

Chengdu University of Traditional Chinese Medicine

OTHER

NCT01350570 - Acupuncture for Patients With Diarrhea-predominant IBS or Functional Diarrhea: a Randomized Controlled Trial | Biotech Hunter | Biotech Hunter